National Outcomes Director – VIASKIN® Peanut

🕒 July 21

🏖️ New Jersey – Remote

🏖️ New Jersey – Remote

💵 $200k - $240k / year

⏰ Full Time

🔴 Lead

👔 Director

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

DBV Technologies

WebsiteLinkedInAll Job Openings

51 - 200 employees

🏥 Healthcare

🍽️ Food & Beverage

🧬 Biotechnology

🔥 Funding within the last year

💰 $30M Post-IPO Secondary - DBV Technologies on 2025-10

Healthcare • Food & Beverage • Biotechnology

DBV Technologies is a global clinical-stage biopharmaceutical company developing epicutaneous immunotherapy to treat food allergies and other immune-mediated diseases. Founded by pediatricians, the company is advancing its proprietary VIASKIN® patch technology through clinical trials—including Phase 3 studies for a peanut allergy patch (DBV712) and earlier-stage programs for milk allergy (DBV135)—with the goal of re-educating the immune system using controlled skin exposure to antigens.

📋 Description

• Act as a subject matter expert on the health outcomes and economic impact of the VIASKIN Peanut Patch and the broader peanut allergy treatment landscape. • Engage with national and regional payers, pharmacy benefit managers, integrated delivery networks, employers, and population health key opinion leaders to provide scientific, clinical, and economic information about VIASKIN Peanut. • Communicate the value proposition of epicutaneous immunotherapy, including efficacy, safety, patch wear-time, and real-world relevance, to support informed coverage and formulary decisions. • Conduct educational programs, scientific presentations, and value-evidence discussions to enhance understanding of product outcomes data among payer and population health audiences. • Establish and maintain strong relationships with key external stakeholders, including medical and pharmacy directors, payer decision-makers, professional societies, and patient advocacy organizations in the food allergy community. • Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses to support informed decision-making by payers and population health customers. • Collaborate with internal cross-functional teams—including Market Access, Medical Affairs, Value & Access, Commercial, and Field Reimbursement—to align evidence strategies and ensure consistent, accurate messaging ahead of and through launch. • Provide training to internal teams on outcomes data and value evidence, ensuring a consistent and accurate understanding across the organization. • Address unsolicited inquiries from payers and population health decision-makers regarding product information, clinical data, and outcomes research, in accordance with applicable regulations and company policy. • Support investigator-initiated studies, real-world evidence generation, and other research initiatives that contribute to the understanding of health outcomes in pediatric peanut allergy. • Contribute to the development of strategic plans for health outcomes research, value-evidence communication, and payer engagement in support of the VIASKIN Peanut launch. • Collaborate with internal stakeholders to integrate health outcomes strategies into broader product launch, access, and commercialization plans. • Ensure that all communication and interactions comply with regulatory requirements, legal guidance, and company policies.

🎯 Requirements

• PharmD, M.D., or Ph.D. in a health sciences–related field required; Master’s in pharmacoepidemiology, epidemiology, or health economics preferred. • Minimum of eight (8) years working in the pharmaceutical, biotechnology, or healthcare industry, with a minimum of five (5) years in a HEOR or payer-facing scientific function supporting product launches with U.S. Market Access teams. • Experience spanning medical and scientific affairs, outcomes research, clinical practice, academic, or U.S. managed-markets settings. • Therapeutic experience in allergy/immunology, pediatrics, and/or rare disease preferred; familiarity with the food allergy treatment landscape is a strong advantage. • Strong understanding of health outcomes research, epidemiology, and health economics. • Demonstrated experience engaging national and regional payers, PBMs, IDNs, and other organized customers in a scientific or value-evidence capacity. • Strong background and deep understanding of health economics, outcomes research methodologies, and evidence-generation techniques. • Demonstrated expertise in economic modeling, budget-impact analysis, data analysis, and interpreting clinical and real-world data to generate meaningful insights. • Stay updated on the latest industry trends, healthcare policies, and regulations impacting health economics and outcomes research, including those specific to pediatric and food allergy markets. • Maintain a deep understanding of therapeutic areas of interest to the organization, including disease mechanisms, the treatment landscape, and relevant market dynamics. • Excellent communication and presentation skills. • Strong proficiency with relevant regulatory guidelines and requirements related to HEOR studies and payer scientific exchange. • Understanding of compliance and ethical considerations in conducting research and engaging with payer decision-makers. • Possess excellent written and verbal communication skills to effectively convey complex HEOR concepts to both technical and non-technical stakeholders. • Ability to engage and build strong relationships with external stakeholders, including thought leaders and academic experts in the field of HEOR.